ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
97,717.78
-0.40%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Revive Therapeutics Ltd (QB) (RVVTF) Quote

Revive Therapeutics Ltd (QB)

Revive Therapeutics Ltd (QB) (RVVTF)

USOTC
0.00555
0.00035
(6.73%)
Closed January 04 4:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.00555
Bid
0.0014
Ask
0.012
Volume
176,239
0.0052 Day's Range 0.00555
0.005 52 Week Range 0.036
Market Cap
2.323M
Previous Close
0.0052
Open
0.0052
Last Trade
1000
@
0.00555
Last Trade Time
Financial Volume
$ 921
VWAP
0.005226
Average Volume (3m)
498,115
Shares Outstanding
418,564,269
Dividend Yield
-
PE Ratio
-5.97
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-5.62M

About Revive Therapeutics Ltd (QB)

Sector
Pharmaceutical Preparations
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.revivethera.com
Headquarters
Toronto, Ontario, Can
Founded
2014
Revive Therapeutics Ltd (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RVVTF. The last closing price for Revive Therapeutics (QB) was $0.01. Over the last year, Revive Therapeutics (QB) shares have traded in a share price range of $ 0.005 to $ 0.036.

Revive Therapeutics (QB) currently has 418,564,269 shares outstanding. The market capitalization of Revive Therapeutics (QB) is $2.18 million. Revive Therapeutics (QB) has a price to earnings ratio (PE ratio) of -5.97.

Ask ADVFN Intelligence (AI)

RVVTF Latest News

More News

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

April 18 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

April 12 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

March 29 2022
InvestorsHub NewsWire

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

                              HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...

February 24 2022
InvestorsHub NewsWire

Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation

 Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation  TORONTO, February 15, 2022 -- Revive...

February 16 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

February 14 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...

January 19 2022
InvestorsHub NewsWire

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

January 17 2022
InvestorsHub NewsWire

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

January 07 2022
InvestorsHub NewsWire

Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant

 Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...

November 16 2021
InvestorsHub NewsWire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.00055-9.016393442620.00610.00670.0055879210.00609589CS
4-0.00095-14.61538461540.00650.007780.0054299320.00627017CS
12-0.00035-5.932203389830.00590.0120.0054981150.0069545CS
26-0.00145-20.71428571430.0070.01350.0053901830.00755605CS
52-0.01545-73.57142857140.0210.0360.0053558780.01338928CS
156-0.24445-97.780.250.390.0054325510.10803825CS
260-0.03105-84.83606557380.03660.720.00510595140.27562086CS

RVVTF - Frequently Asked Questions (FAQ)

What is the current Revive Therapeutics (QB) share price?
The current share price of Revive Therapeutics (QB) is $ 0.00555
How many Revive Therapeutics (QB) shares are in issue?
Revive Therapeutics (QB) has 418,564,269 shares in issue
What is the market cap of Revive Therapeutics (QB)?
The market capitalisation of Revive Therapeutics (QB) is USD 2.18M
What is the 1 year trading range for Revive Therapeutics (QB) share price?
Revive Therapeutics (QB) has traded in the range of $ 0.005 to $ 0.036 during the past year
What is the PE ratio of Revive Therapeutics (QB)?
The price to earnings ratio of Revive Therapeutics (QB) is -5.97
What is the reporting currency for Revive Therapeutics (QB)?
Revive Therapeutics (QB) reports financial results in CAD
What is the latest annual profit for Revive Therapeutics (QB)?
The latest annual profit of Revive Therapeutics (QB) is CAD -5.62M
What is the registered address of Revive Therapeutics (QB)?
The registered address for Revive Therapeutics (QB) is 82 RICHMOND STREET EAST, SUITE 105, TORONTO, ONTARIO, M5C 1P1
What is the Revive Therapeutics (QB) website address?
The website address for Revive Therapeutics (QB) is www.revivethera.com
Which industry sector does Revive Therapeutics (QB) operate in?
Revive Therapeutics (QB) operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGIOQEdgio Inc (CE)
$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
$ 0.00125
(-10.71%)
169.44M

RVVTF Discussion

View Posts
govprs govprs 1 week ago
Lol 
👍️0
rickstereo3333 rickstereo3333 1 week ago
Things may look much better for Small Pharmacos with the new incoming admin (if they allow JFKs confirmation) because the playing field should be more equitable as opposed to the past.

Hopefully Bucillamine will get looked over once again by the authorities as a potentially safe and effective multi use therapeutic for a host of maladies.

AIMHOOC
👍️ 1 🙏 1
Classic Warrior Classic Warrior 4 weeks ago
That's a relief. I'm down a few cents.
👍️0
KimKhaos5 KimKhaos5 1 month ago
Shroom Boom. Psychedelic Therapy. 
👍️0
Milesblue42 Milesblue42 2 months ago
NO PUMP....but a Crazy thought....

1st this is in no way a PUMP Idea.

2nd We don't know if RFK Jr will be confirmed. But just the mention of him being selected by DT sent a lot of BP stocks down.

3rd if RFK Jr is confirmed somehow and his preference for more natural remedies would that make RVVTF finally attractive to BP?


https://www.cnbc.com/2024/11/14/vaccine-maker-stocks-fall-as-trump-chooses-rfk-jr-to-lead-hhs.html
👍️0
Milesblue42 Milesblue42 2 months ago
Ceo Frank being reported as well???

Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.

Pure Comedy 😄
👍️0
cfoofme cfoofme 2 months ago
Forward scamming trust bots to the SEC for making a stock appear to be a scam to newbies.
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
Price prediction
🥸 1
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
Shareholders post
🤓 1
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
Speculating, wonder if market capitalization, miracle, if goes to billions , maybe fka billion
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
Interesting stock price
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
A lot of debt
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
What makes you come up with $4
👍️0
Snoop_dog Snoop_dog 2 months ago
$4 might finally be her JFK at the FDA.
👍️0
Snoop_dog Snoop_dog 2 months ago
They should jump on it H5N1 next COVID.
👍️0
Snoop_dog Snoop_dog 2 months ago
Any one knows if they work on H5N1?
👍️0
lolroflmao lolroflmao 2 months ago
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke Nov 12, 2024

https://revivethera.com/2024/11/revive-therapeutics-announces-publication-demonstrating-novel-therapeutic-approach-of-psilocybin-in-stroke/
👍️ 2 💥 1
lolroflmao lolroflmao 2 months ago


👍️0
Ecomike Ecomike 2 months ago
That dog is all bark and no bite. Ignore him
👎️ 1
Gatorca Gatorca 2 months ago
Maybe another possibility If Buc. work 16x nac...Promising Role of N-Acetylcysteine in Reducing Airway Mucus in COPD Patients
https://x.com/ThailandMedicaX/status/1851274249392308675
Hopefully Cw, Rio seen his reply in reddit lol etc they get it to good Use instead of up mfs a ss Monthly 30k salary
👍️0
lolroflmao lolroflmao 2 months ago
News: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Oct 31, 2024

https://revivethera.com/2024/10/revive-therapeutics-provides-update-on-research-study-evaluating-bucillamine-for-nerve-agent-exposure-2/
👍️ 1
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
One to watch
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
0.0001
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 2 months ago
Interesting company
👍️0
Gatorca Gatorca 3 months ago
Derrick might be a better possible Ceo at this point with Shrooms lol ) what about the possible cancer fighting Shrooms?
Ps. Sorry forgot the name of that shroom type possibility..
Pss. Waiting on my Domino's lol..but not Mf. but honestlyhope eventuallyit works our Cw ops 5 shots pizza done heheh..
👍️0
Gatorca Gatorca 3 months ago
I just hope 🙏 you ok
👍️ 1
Classic Warrior Classic Warrior 3 months ago
Yea. It's my biggest loss, but I my optimism is all but gone. Mistakes were made for sure, but hopefully, the Canadian Department of Defense will see something in the drug and save the day. I still wonder what Derrick has been doing on the psychedelic side and the weed angle. What about those patented strips? I'd say we have about a 3% chance of recovery, but I have been wrong before and hope I am again.

ps. Good luck, but profits elsewhere may be more realistic at this time.
💯 1
Gatorca Gatorca 3 months ago
Just Sucks Cw all I can say now bucy good but Chit ceo etc...
Maybe try some other stocks with some ot money
Ps. Still trying to get it back Lol..but have good chance I think will see...
👍️0
JoeBenson JoeBenson 3 months ago
Well you should know Giovanni, nobody has spewed more BS on this board than you have.
👍️0
Giovanni Giovanni 3 months ago
All Is Fine was total BS.
👍️ 2 💯 2
JoeBenson JoeBenson 3 months ago
"What false allegations did MF make?"

👍️0
Milesblue42 Milesblue42 4 months ago
What do you mean? Explain please

OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.

What false allegations did MF make?
👍️0
Snoop_dog Snoop_dog 4 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
💯 1
Snoop_dog Snoop_dog 4 months ago
OMG .Oo7 how the long covid. The CEO needs to go to jail!!! Making false allegations about his product. Promises that never came true. Literally he should go to prison for financial fraud. Can't even hold a penny. MF I hope a bus comes by an pick you up. When we will get a new CEO. f joke. I hope he comes to Chicago we could show him the Chicago smile and the hospitality.
👍️0
powerbattles powerbattles 4 months ago
Nobody cares and not enough volume to cover the cost issue of the news.
👍️0
lolroflmao lolroflmao 4 months ago
NEWS: Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

SEP 18, 2024


https://revivethera.com/2024/09/revive-therapeutics-announces-strategic-focus-on-bucillamine-for-infectious-diseases-and-medical-countermeasures/
👍️ 1
medicinecat medicinecat 4 months ago
👍️ 1
Hotel Delta Hotel Delta 4 months ago
It'll go back up, buy now if you want to make a little money.
👍️0
mrfumbles mrfumbles 4 months ago
Down down down
👍️0
govprs govprs 4 months ago
Omg.
👍️0
JoeBenson JoeBenson 4 months ago
👍️0
Classic Warrior Classic Warrior 4 months ago
Almost made back all the money I lost by working overtime, PB. I haven't sold a share but hope for a miracle. If I bought the same number of shares today, I'd own 50% of the company with MF.

ps. more delays. Didn't see that coming although I'm not sure we can blame the big guy for that one. Monkeypox- here we come.
👍️0
powerbattles powerbattles 4 months ago
Bucillamine showed promise, but MF is a con man. It's very sad to see that MF is taking advantage, he treats shareholders like ATMs to cover his personal expenses. I still see many loyal shareholders posting here. At this point, it's a choice between moving on or holding out for a miracle, which could still happen.
👍️ 1
Milesblue42 Milesblue42 4 months ago
Bucillamine cures every Damn Thing

Is this the Real Deal.....this time?

Will Mr. Frank ever come through??
👍️0
stocktowatch stocktowatch 4 months ago
$RVVTF Breaking News! Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections https://finance.yahoo.com/news/revive-therapeutics-provides-research-study-110000328.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via
@YahooFinance
👍️0
Gatorca Gatorca 4 months ago
Yes your right as fck....lol

Ps. But bucillamine can work if the Ceo wasn't such a Dumb ass.....he just want his 30k salary what a piece of Chit yea fo Golfing fck investors his so Dumb .....
👍️0
MB1972 MB1972 4 months ago
You and everyone else..MF stole all the money from the shareholders collecting a six figure salary and running this into the ground...only a miracle can get us out of this mess imo
👍️ 1 💯 1
govprs govprs 5 months ago
You’re such a bag holder!!!!
👍️0
govprs govprs 5 months ago
Investing in Rvvtf is like drinking tequila and puking hard


MF is the biggest scam artist. If I could puke all over him right now I would
👍️0
medicinecat medicinecat 5 months ago
Investing in RVVTF and drinking go together like peanut butter and jelly. Good luck my man.
👍️ 1 💯 1

Your Recent History

USOTC
RVVTF
Revive Therapeutics (QB)
BIT
P18QQ7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads